0001246360-15-001885.txt : 20150429
0001246360-15-001885.hdr.sgml : 20150429
20150429172809
ACCESSION NUMBER: 0001246360-15-001885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150427
FILED AS OF DATE: 20150429
DATE AS OF CHANGE: 20150429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quinn Anthony
CENTRAL INDEX KEY: 0001532219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 15814172
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2015-04-27
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001532219
Quinn Anthony
33 HAYDEN AVE
LEXINGTON
MA
02421
false
true
false
false
EVP, CMO & Head of R&D
Common Stock
2015-04-27
4
M
false
10000
1.7
A
15637
D
Common Stock
2015-04-27
4
S
false
10000
110
D
5637
D
Stock Option (Right to Buy)
1.7
2015-04-27
4
M
false
10000
0
D
2021-05-25
Common Stock
10000
37228
D
The sale of shares of the Company's common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 6, 2015.
The Stock Option granted the reporting person an option to purchase 47,228 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 05/25/2012, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.
/s/ Anthony Quinn
2015-04-29